Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

類似資料

• Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real‐World Clinical Setting
  著者:: Yamaguchi, Kensei, 等
  出版事項: (2019)
• Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
  著者:: Doi, Toshihiko, 等
  出版事項: (2015)
• Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer
  著者:: Komatsu, Yoshito, 等
  出版事項: (2013)
• A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
  著者:: Yoshino, Takayuki, 等
  出版事項: (2012)
• Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912
  著者:: Takahari, Daisuke, 等
  出版事項: (2014)